New search | Conferencedetail
Print view

2nd Anti-Fibrotic Drug Development Summit (AFDD)

evvnt Platform / evvnt
Conference themes
AFDD (Anti-Fibrotic Drug Development) is the industry definitive fibrosis forum for drug developers focused on organ specific indications to gain cross-disciplinary insights into the next generation of candidates.

Join fibrosis leaders as they address challenges in anti-fibrotic drug development through a tighter lens.
Professional congress organizer (PCO)
Hanson Wade
Speakers: Alexey Lugovsky, Chief Development Officer Morphic, Therapeutics, Andy Blanchard, Director External Discovery, GSK, Charles Theuer, Chief Executive Officer, Tracon Pharmaceuticals

Enquiries and Registration:
Ms. Aarti Diwan
Health Services, Pharmacology and Toxicology
Congress fees
USD 2.799,00
(Conference (Standard): USD 2799.0 Conference (Early bird ends Friday August 24, 2018): USD 2499.0 Conference (Early bird ends Friday September 21, 2018): USD 2599.0 Conference (Early bird ends Friday October 19, 2018): USD 2699.0)
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Österreichische Akademie der ÄrzteCentro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioHelix - Forschung & Beratung WienAMREF - African Medical and Research FoundationAnästhesie in Entwicklungsländern e. V.European Public Health Association (EUPHA)OÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation newTree